The structure-based cancer-related single amino acid variation prediction.

Journal: Scientific reports
PMID:

Abstract

Single amino acid variation (SAV) is an amino acid substitution of the protein sequence that can potentially influence the entire protein structure or function, as well as its binding affinity. Protein destabilization is related to diseases, including several cancers, although using traditional experiments to clarify the relationship between SAVs and cancer uses much time and resources. Some SAV prediction methods use computational approaches, with most predicting SAV-induced changes in protein stability. In this investigation, all SAV characteristics generated from protein sequences, structures and the microenvironment were converted into feature vectors and fed into an integrated predicting system using a support vector machine and genetic algorithm. Critical features were used to estimate the relationship between their properties and cancers caused by SAVs. We describe how we developed a prediction system based on protein sequences and structure that is capable of distinguishing if the SAV is related to cancer or not. The five-fold cross-validation performance of our system is 89.73% for the accuracy, 0.74 for the Matthews correlation coefficient, and 0.81 for the F1 score. We have built an online prediction server, CanSavPre ( http://bioinfo.cmu.edu.tw/CanSavPre/ ), which is expected to become a useful, practical tool for cancer research and precision medicine.

Authors

  • Jia-Jun Liu
    The Ph.D. Program of Biotechnology and Biomedical Industry, China Medical University, Taichung, Taiwan.
  • Chin-Sheng Yu
    Department of Information Engineering and Computer Science, Feng Chia University, Taichung, Taiwan.
  • Hsiao-Wei Wu
    Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
  • Yu-Jen Chang
    The Ph.D. Program of Biotechnology and Biomedical Industry, China Medical University, Taichung, Taiwan.
  • Chih-Peng Lin
    Yourgene Bioscience, No.376-5 Fuxing Rd., Shulin Dist, New Taipei City, 238, Taiwan.
  • Chih-Hao Lu
    The Ph.D. Program of Biotechnology and Biomedical Industry, China Medical University, Taichung, Taiwan. chlu@mail.cmu.edu.tw.